Test-retest repeatability of quantitative radiomics features of FDG PETCT studies in patients with diffuse large B cell lymphoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON25380

Enrollment

Registered

2019-09-17

Start date

2019-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse Large B-Cell lymphoma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - Patient age 18 years or older - Diagnosed with diffuse large B cell lymphoma - At least one tumour with diameter ? 3cm (to minimize partial volume effects) - Able to remain supine for 30 minutes in the PET-CT scanner - Written and signed informed consent

Exclusion criteria

Exclusion criteria: - Chemotherapy in the past 4 weeks - Multiple malignancies - Pregnant or lactating patients - Metal implants (e.g. pacemakers) - Any medical, physiological or social condition that may interfere with the subject’s safety and participation in the study, will lead to exclusion from this study

Design outcomes

Primary

Measure	Time frame
test-retest repeatability of radiomics features	—

Contacts

Public ContactCorinne Eertink

Amsterdam UMC- location VUmc

j.eertink@amsterdamumc.nl02044445057

Outcome results